Related Experiment Video

Updated: Mar 9, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.3K

Antibiotic dosing for multidrug-resistant pathogen pneumonia

Mohd H Abdul-Aziz1, Jeffrey Lipman, Jason A Roberts

  • 1aBurns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia bSchool of Pharmacy, International Islamic University of Malaysia, Kuantan, Pahang, Malaysia cDepartment of Intensive Care Medicine dPharmacy Department, Royal Brisbane and Women's Hospital eCentre for Translational Antiinfective Pharmacodynamics, The University of Queensland, Brisbane, Australia.

Current Opinion in Infectious Diseases
|December 29, 2016
PubMed
Abstract

Insights

Optimizing antibiotic dosing is crucial for treating multidrug-resistant nosocomial pneumonia in ICUs. Tailoring regimens based on pharmacokinetic/pharmacodynamic data improves outcomes for critically ill patients.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Nosocomial pneumonia caused by multidrug-resistant pathogens is a growing concern in intensive care units (ICUs).
  • These infections are linked to poorer patient outcomes.
  • Optimizing antibiotic dosing is a key strategy to improve treatment efficacy.

Purpose of the Study:

  • To review recent pharmacokinetic/pharmacodynamic (PK/PD) data relevant to antibiotic dosing for nosocomial pneumonia.
  • To highlight the challenges in treating infections caused by multidrug-resistant pathogens in critically ill patients.
  • To inform optimal antibiotic strategies for improved clinical outcomes.

Main Methods:

  • Review of current pharmacokinetic/pharmacodynamic data.
  • Analysis of challenges in antibiotic dosing for critically ill patients.
  • Evaluation of PK/PD principles for optimizing drug exposure.

Main Results:

  • Standard dosing guidelines often fail to account for altered physiology in critically ill patients.
  • Plasma drug concentrations may not correlate with concentrations at the infection site.
  • Aggressive dosing strategies, guided by PK/PD characteristics, are necessary for effective lung tissue drug exposure.

Conclusions:

  • Conventional antibiotic dosing strategies are associated with a higher risk of therapeutic failure in critically ill patients.
  • Alternative dosing strategies leveraging antibiotic PK/PD properties are essential.
  • Optimized antibiotic exposure through tailored dosing can lead to better therapeutic outcomes.

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.5K
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

34.2K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
991
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
305
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
573
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
383